scholarly journals CD20+ B-cell depletion therapy suppresses murine CD8+ T-cell–mediated immune thrombocytopenia

Blood ◽  
2016 ◽  
Vol 127 (6) ◽  
pp. 735-738 ◽  
Author(s):  
Li Guo ◽  
Rick Kapur ◽  
Rukshana Aslam ◽  
Edwin R. Speck ◽  
Anne Zufferey ◽  
...  

Key Points CD20 Bdep therapy inhibits CD8+ T-cell proliferation in vitro. CD20 Bdep therapy prevents CD8+ T-cell–mediated ITP in vivo.

2009 ◽  
Vol 131 ◽  
pp. S68-S69
Author(s):  
Danice Wilkins ◽  
Kory Alderson ◽  
Myriam Bouchlaka ◽  
Doug Redelman ◽  
Lisbeth Welniak ◽  
...  

2007 ◽  
Vol 204 (8) ◽  
pp. 1803-1812 ◽  
Author(s):  
Daisuke Kamimura ◽  
Michael J. Bevan

An optimal CD8+ T cell response requires signals from the T cell receptor (TCR), co-stimulatory molecules, and cytokines. In most cases, the relative contribution of these signals to CD8+ T cell proliferation, accumulation, effector function, and differentiation to memory is unknown. Recent work (Boyman, O., M. Kovar, M.P. Rubinstein, C.D. Surh, and J. Sprent. 2006. Science. 311:1924–1927; Kamimura, D., Y. Sawa, M. Sato, E. Agung, T. Hirano, and M. Murakami. 2006. J. Immunol. 177:306–314) has shown that anti–interleukin (IL) 2 monoclonal antibodies that are neutralizing in vitro enhance the potency of IL-2 in vivo. We investigated the role of IL-2 signals in driving CD8+ T cell proliferation in the absence of TCR stimulation by foreign antigen. IL-2 signals induced rapid activation of signal transducer and activator of transcription 5 in all CD8+ T cells, both naive and memory phenotype, and promoted the differentiation of naive CD8+ T cells into effector cells. IL-2–anti–IL-2 complexes induced proliferation of naive CD8+ T cells in an environment with limited access to self–major histocompatibility complex (MHC) and when competition for self-MHC ligands was severe. After transfer into wild-type animals, IL-2–activated CD8+ T cells attained and maintained a central memory phenotype and protected against lethal bacterial infection. IL-2–anti–IL-2 complex–driven memory-like CD8+ T cells had incomplete cellular fitness compared with antigen-driven memory cells regarding homeostatic turnover and cytokine production. These results suggest that intense IL-2 signals, with limited contribution from the TCR, program the differentiation of protective memory-like CD8+ cells but are insufficient to guarantee overall cellular fitness.


2009 ◽  
Vol 183 (6) ◽  
pp. 3751-3760 ◽  
Author(s):  
Anna Maria Wolf ◽  
Kathrin Eller ◽  
Robert Zeiser ◽  
Christoph Dürr ◽  
Ulrike V. Gerlach ◽  
...  

Blood ◽  
2009 ◽  
Vol 113 (12) ◽  
pp. 2673-2683 ◽  
Author(s):  
Khaleda Rahman Qazi ◽  
Ulf Gehrmann ◽  
Emilie Domange Jordö ◽  
Mikael C. I. Karlsson ◽  
Susanne Gabrielsson

Abstract Exosomes are nanovesicles harboring proteins important for antigen presentation. We compared the potency of differently loaded exosomes, directly loaded with OVA323-339 peptide (Pep-Exo) or exosomes from OVA-pulsed DCs (OVA-Exo), for their ability to induce specific T-cell proliferation in vitro and in vivo. Both Pep-Exo and OVA-Exo elicited specific transgenic T-cell proliferation in vitro, with the Pep-Exo being more efficient. In contrast, only OVA-Exo induced specific T-cell responses in vivo highlighting the importance of indirect loading strategies in clinical applications. Coadministration of whole OVA overcame the unresponsiveness with Pep-Exo but still elicited a lower response compared with OVA-Exo. In parallel, we found that OVA-Exo not only augmented the specific T-cell response but also gave a Th1-type shift and an antibody response even in the absence of whole OVA. We detected IgG2a and interferon-γ production from splenocytes showing the capability of exosomes to provide antigen for B-cell activation. Furthermore, we found that B cells are needed for exosomal T-cell stimulation because Bruton tyrosine kinase–deficient mice showed abrogated B- and T-cell responses after OVA-Exo immunization. These findings reveal that exosomes are potent immune regulators and are relevant for the design of vaccine adjuvants and therapeutic intervention strategies to modulate immune responses.


2013 ◽  
Vol 19 (2) ◽  
pp. S340
Author(s):  
Sabarinath Venniyil Radhakrishnan ◽  
Fridrik J. Karlsson ◽  
Senthilnathan Palaniyandi ◽  
Gerhard C. Hildebrandt

Sign in / Sign up

Export Citation Format

Share Document